West Nile virus breaks out in Texas; PATH Malaria Vaccine Initiative names scientists to advisory council;

> PATH Malaria Vaccine Initiative named malaria scientists and vaccinologists to its advisory council. Release

> The New Jersey Supreme Court halted a lawsuit filed by a man claiming that a polio vaccine he received in the 1970s caused a brain tumor. Story

> FDA cleared the Infectious Disease Research Institute and Medicago to initiate a Phase I clinical trial for an H5N1 avian influenza VLP vaccine candidate. Release

> Genocea Biosciences initiated a Phase I/IIa clinical study with its lead investigational herpes vaccine candidate, GEN-003. Release

> Novavax and PATH teamed up to develop Novavax's RSV vaccine to protect infants through maternal immunization in low-resource countries. Article

And Finally... Nine people in Dallas County, TX, have died from a West Nile virus outbreak that infected 175 people. News

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.